In a series of experiments performed in hamsters and mice, administration of mixtures of detergent-disrupted (SV) influenza A X49 (H3N2) virus and inactivated X49 whole virus (WV) vaccine induced lower serum antibody titres than equivalent or lower doses of WV vaccine alone. This reduction in antibody titre was also observed using influenza A (HIN1) and influenza B (B/Hong Kong/8/73) SV and WV vaccine preparations. The results suggested that SV preparations can suppress the serum antibody response to WV vaccine. A suppressive effect of SV influenza virus on WV vaccine was also observed in an in vitro antibody-forming system, using primed mouse spleen cells. In this system, SV induced markedly lower IgG and IgM antibody responses than WV vaccine, and mixtures of SV with WV reproducibly resulted in lowered antibody responses compared to those elicited by WV alone. Possible reasons for these findings are discussed in the light of the known low immunogenicity observed for split and subunit influenza virus vaccine preparations in animals and in unprimed human populations.
INTRODUCTION
Detergent-split, subunit influenza virus vaccines (SV) containing predominantly haemagglutinin (HA) and neuraminidase (NA) components are associated with a low incidence of reactogenicity, especially in children (Gross et al., 1980; Jennings et al., 1981 a) , However, many reports are witness to the relatively poor immunogenicity of these vaccine preparations in animals and in unprimed humans (Barry et al., 1974; Eastwood et al., 1979) and two doses of such preparations are required to induce acceptable antibody levels (Gross & Ennis, 1977; Eastwood et al., 1979) . Attempts to enhance the immunogenicity of SV vaccines have included the use of adjuvanted preparations such as aluminium hydroxide gel-adsorbed SV (Davenport, 1968 ; Jennings et al., 1975 ; Potter et al., 1975) , SV with bacterial peptidoglycans (Audibert et al., 1977; Crawford et al., 1982) , and SV incorporated into liposomes (Thibodeau et al., 1981; Hackett et al., 1983) . One further method aimed at enhancing the immune response to influenza virus subunits was the inclusion of low doses of heterologous or homologous, inactivated whole virus (WV) particles in SV preparations (Laver & Webster, 1976; Webster et al., 1977) .
In studies from this laboratory, a zwitterionic detergent has been used to obtain influenza virus SV preparations and these preparations have been found to have low immunogenicity for animals compared to inactivated WV vaccine used at equivalent dosages (Mukhlis et al., 1984) . In attempts to enhance immunogenicity, WV was incorporated with these SV preparations as described by Webster et al. (1977) . The results indicated that although immune potentiation of SV preparations was obtained, there was an overall suppression of the serum antibody response. Further studies showed that differences in the immune responses to WV and SV, and a suppressive effect of the latter preparation on the antibody levels elicited in response to the former could also be detected in an in vitro antibodyforming system.
METHODS
Virus vaccine preparation and standardization. Concentrated, fl-propiolactone-inactivated (WV) preparations of influenza A/Dunedin/7/83 (HINt), B/Hong Kong/8/73, and reassortant X49 (H3N2; A/PR/8/34 x A/England/864/75) were kindly donated by Duphar Laboratories, Weesp, The Netherlands. SV preparations were obtained by treatment of intact vaccines with 0.5~ of the zwitterionic detergent Empigen BB for 18 h. The detergent-treated preparations were subjected to ultracentrifugation at 75000g for 60 min at 4°C and dialysis against phosphate-buffered saline pH 7.2 (PBS) for 48 to 72 h at 4 °C, to remove detergent. In most experiments, the preparations used were further purified by sucrose density gradient centrifugation . SV preparations contained primarily viral HA and NA, relatively little viral nucleoprotein, and no matrix protein .
The HA content (HAU) of whole and detergent-split SV preparations was determined by single radial diffusion (Wood et al., 1977) . Standard antigens and antisera were kindly supplied by the National Institute for Biological Standards and Control, London, U.K.
Viruses. Influenza X49 virus for use in single radial haemolysis (SRH) tests was available in our laboratory as egg-grown stock.
Animals. Eight-to 12-week-old Syrian hamsters and 6-to 8-week-old female BALB/c mice were obtained from closed colonies at the University of Sheffield.
Serological tests
Haemagglutination-inhibition tests. HI tests were carried out according to standard procedures (Jennings et al., 1981a) .
Single radial haemolysis tests. SRH tests, carried out as described elsewhere , were used to assay antibodies to X49 virus in hamster sera. Standard reference sera raised against X49 WV vaccine were included in each immunoplate and the antigen used was egg-grown X49 virus stock.
Enzyme-linked immunosorbent assay. Essentially, an ELISA method described in detail elsewhere (Jennings et al., 1981 b) was used to measure antibody in mouse and hamster sera and in supernatants from in vitro spleen cell cultures, except that peroxidase-conjugated reagents and the substrate o-phenylenediamine were used. Standard, influenza antibody-positive or -negative mouse or hamster antisera prepared in this laboratory were included on all plates. Peroxidase-conjugated goat and rabbit anti-mouse immunoglobulin sera (Sigma) were used to detect IgM or IgG antibodies respectively, in mouse sera and in mouse spleen cell culture supernatants. Peroxidase conjugated rabbit anti-hamster immunoglobulin serum (Nordic Immunological Laboratories, Maidenhead, U.K.) was used in tests for hamster IgG antibody. Concentrated, egg-grown influenza X49, A/Dunedin or B/Hong Kong/73 virus antigens were titrated in a chequerboard fashion against enzyme conjugate, and the dilutions and conjugate used in ELISA were those giving absorbance readings of 1-00 with standard positive sera and < 0-1 with negative sera. Absorbances of each reaction were measured at 490 nm using a Microelisa Minireader (Dynatech, Billingshurst, UK.).
In the in vivo studies, mouse or hamster sera were all tested at a dilution of 1 : 100 and the ELISA antibody values were calculated using the following equation: [(A of test serum -A of negative serum)/(A of positive serum -A of negative serum)] x dilution factor.
In the in vitro studies, all spleen cell culture supernatants were tested by ELISA at a dilution of 1:2, and expressed as the absorbance values obtained at that dilution.
Experimental procedures
Combined inoculations of WV vaccine and S V preparations in animals. Influenza virus vaccine preparations were diluted in PBS and combined to contain specific ~tg HA quantities of WV vaccines and SV. These suspensions were inoculated intramuscularly (i.m.) into the hind leg of hamsters or mice in single 0.5 ml or 0.2 ml volumes respectively. Blood samples for assessment of serum antibody responses were collected from 9 to 36 days later depending upon experimental design.
Preparation of mouse spleen cell suspensions. Mice were killed by cervical dislocation, their spleens were removed to chilled Hanks' balanced salt solution (HBSS), fragmented and gently passed through a 120-gauge stainless steel mesh. Released cells were washed three times and resuspended in HBSS. Viable cell numbers were calculated by a trypan blue exclusion test.
In vitro spleen cell cultures. Essentially, the methods of Anders et al. (1979 Anders et al. ( , 1981 were used. Spleen cell cultures from mice primed 3 to 4 months previously with 200 HAU of live X49 virus given intraperitoneally were cultured (2 × l0 T cells/well) in 24-well tissue culture plates (Flow Laboratories) in the presence of various concentrations of WV or SV preparations, or mixtures of the two, for 7 days at 37 °C in a humidified atmosphere (5~o CO, in air). The culture medium used throughout was Eagle's MEM plus non-essential amino acids supplemented with 10~ heat-inactivated foetal calf serum, 10 -4 M-2-mercaptoethanol and 30 p.g/ml gentamicin. At least two spleen cell culture replicates were used at each concentration for each WV vaccine, SV preparation or WV/SV vaccine mixture tested, and control spleen cell cultures, with no vaccine preparation present, were included in all experiments. After 7 days incubation, spleen cell culture supernatants were harvested and stored at -20 °C until assay for virus-specific antibody by ELISA.
Prior experiments were carried out to establish the optimum spleen cell concentration, WV vaccine concentration and time needed to elicit the maximum IgG and IgM antibody levels in vitro.
RESULTS

Potentiation of the antibody response of hamsters to influenza S V vaccine by homologous WV vaccine
Six groups, each of 10 hamsters were inoculated i.m. with 5, 10 or 20gg HA of X49 SV preparation alone, or with a mixture consisting of SV supplemented with 2 ~g HA of X49 WV vaccine. Two further groups received 2 or 20 gg HA of WV vaccine alone. Twelve days later blood samples were collected from each animal, the sera were separated and tested individually for their HI antibody levels. The results (Fig. 1) show that 5, 10 or 20 gg HA of SV alone elicited mean serum HI antibody levels of 1 : 19, 1 : 10 and 1 : 12 respectively, while hamsters inoculated with equivalent amounts of SV together with 2 gg of WV vaccine responded with markedly higher antibody titres. However, none of the groups receiving SV alone or SV/WV mixtures responded with antibody levels as high as those seen in animals receiving either 2 or 20 gg HA of WV vaccine alone. Table 1 shows the results of experiments in which antibody levels were measured, using HI, SRH or ELISA tests, in sera from animals (hamsters or mice) which had received SV or WV vaccine alone or the two together 9 to 12 days previously. In experiment 1, hamsters receiving WV vaccine alone (2 pg HA) showed a mean HI antibody titre of 53.4. However, on inoculation with mixtures containing 2 ~tg HA of WV and increasing amounts, 5, 10, or 20 gg HA, of SV, progressively lower mean serum HI antibody titres, respectively 42.4, 24.2 and 14-9, were obtained. Control groups receiving 20 ~g HA of WV or SV alone, showed HI titres of 333.2 and 12.3 respectively. In experiment 2, hamsters immunized with 2 or 6 ~tg HA of SV mixed with 2 ~tg HA WV vaccine showed mean SRH antibody levels of 20.1 and < 10, both correspondingly lower than the level, 26.7, observed in animals receiving 2 gg HA of WV vaccine alone. Experiment 3 (Table 1) shows that hamsters immunized with 3, 9 or 27 ~g HA of WV vaccine mixed with 10 gg HA of the SV preparation all responded with significantly lower virus-specific IgG antibody levels as determined by ELISA than animals receiving equivalent amounts of WV vaccine alone. Further experiments (4, 5 and 6) carried out in mice using density gradientpurified SV gave essentially similar results. In all three experiments, inoculation of mixtures of 8 gg HA of SV with either 4 or 8 gg HA of WV vaccine resulted, in several instances, in significantly reduced ELISA IgG or IgM antibody responses compared to those observed in mice receiving equivalent doses of WV vaccine alone (Table 1) . Table 2 shows that mock, Empigen-treated preparations obtained by the addition of 0.5 Empigen to PBS with subsequent ultracentrifugation and dialysis as described for the preparation of SV, had no suppressive effect on the antibody response to X49 WV vaccine. The mock detergent-treated preparations were used at dilutions equivalent to 10 (experiment 1) or 2.5 (experiment 2) ~tg HA of SV.
Reduction in overall antibody response in animals inoculated with )(49 WV and SV vaccine mixtures
Effect of time on antibody suppression associated with SV vaccine
Five groups of ten hamsters were inoculated i.m. with 2, 7, 12, 22 or 42 gg HA of X49 WV alone, while a further four groups each of 10 hamsters received vaccine mixtures each containing 2 lag HA of X49 virus together with 5, 10, 20 or 40 pg of WV vaccine. Thus the total gg HA in each of these mixtures was equivalent to that received by the first set of animals given WV alone. Serum antibody levels were determined by SRH 9, 19 and 36 days later. The results (Fig. 2) show that in hamsters receiving 2 gg HA of WV vaccine there was no SRH antibody response at 9 or 19 days; animals receiving either 7 ~tg HA of WV vaccine or 7 ~tg HA total of a vaccine mixture (2 ~tg SV and 5 ~tg WV vaccine), also showed no antibody response at 9 days. However, there was a reduced antibody response at 9 days in those animals receiving mixtures of 10, 20 or 40 ~tg HA of WV plus 2 gg HA of SV, compared to that seen in animals receiving WV vaccine alone. After 19 and 36 days, SRH antibody levels were higher, but significantly reduced levels were again apparent in sera from animals receiving vaccine mixtures. Table 3 shows the results of experiments, using A/Dunedin, or B/Hong Kong influenza virus, in which the antibody response of hamsters was measured 9 and 21 days after immunization with SV/WV vaccine mixtures. Virus-specific IgG levels as determined by ELISA showed that, for both A/Dunedin and B/Hong Kong, at 21 days, animals receiving mixtures of 5 gg HA WV plus 5 lag HA SV produced markedly less antibody than those receiving 5 ~tg HA WV alone. Only low antibody levels were detectable at 9 days in hamsters inoculated with A/Dunedin WV or SV antigen preparations, but the antibody levels to B/Hong Kong preparations at 9 days were significantly lower when SV alone or WV/SV mixtures were inoculated, compared to those observed following WV vaccine alone. Titres from control groups, given WV or SV alone, demonstrated the much lower titres induced in animals by SV, compared with WV, at equivalent dosages.
Antibody responses of hamsters inoculated with A/Dunedin or B/Hong Kong WV and SV vaccine mixtures
Antibody suppression by SV vaccine in vitro In vitro antibody response to SV or WV vaccine preparations
Spleen cell cultures were prepared from mice primed 3 months previously with X49 virus, and various concentrations of X49 SV or WV vaccine contained in a volume of 0.1 ml were added to make the final culture volume 1-5 ml. Seven days later the supernatants were collected and subsequently assayed for virus-specific IgG and IgM antibody by ELISA. The results of a representative experiment (Fig. 3) show that at all concentrations tested, SV induced very little IgG antibody, compared to the WV vaccine tested over a similar concentration range. In Fig.  3 (b) , the IgM antibody levels elicited in vitro in response to different concentrations of SV or WV vaccine are shown and again, there was a considerable difference between the two, with markedly lower amounts of antibody being induced by the SV preparation. The response of the spleen cell cultures to WV vaccine, in both the IgG and IgM subclasses, occurred over a sharply defined HA concentration range.
In vitro antibody response to SV/WV vaccine mixtures
The antibody response to mixtures of X49WV and SV preparations was assessed in spleen cell cultures from mice primed 3 months previously with X49 virus. The WV vaccine, at a concentration of 0.022 ~tg HA, and the SV preparation at various concentrations were each added in 0.1 ml volumes, to 1.3 ml of spleen cells, to make a final culture volume of 1.5 ml containing 2 × 107 cells. After incubation for 7 days, supernatants were collected and tested for virus-specific IgG and IgM antibodies to X49 virus by ELISA. Table 4 shows the results of three separate experiments, and in each case significant reductions in virus-specific IgG and IgM antibody levels were observed when SV was included in the spleen cell culture along with WV vaccine. The reductions varied from 9 to 87~, the greatest reductions being observed in the presence of higher concentations of SV, although variation between experiments was noted with respect to the degree of reduction in the presence of very similar amounts of the SV preparation.
DISCUSSION
The present results show that administration of mixtures of detergent-disrupted influenza X49 virus and inactivated X49 WV vaccine to hamsters and mice induced lower antibody titres than equivalent or lower doses of WV vaccine alone. This suppression of the antibody response was also observed for influenza A (H1N1) and influenza B (B/Hong Kong/8/73) SV and WV vaccine preparations. The inoculation of WV vaccine with mock detergent-treated preparations showed no evidence of suppressed antibody responses. These in vivo studies were confirmed in vitro. Thus, spleen cell cultures from primed mice exposed to SV failed to respond with the production of either IgM or IgG antibody, although similar cell populations responded well to WV vaccine. When WV and SV preparations were added together to primed spleen cell cultures in vitro, both IgG and IgM antibody levels were significantly reduced, compared to those observed when WV vaccine alone was used. However, reduced antibody levels were not consistently observed in vitro, suggesting that small variations in relative WV and SV antigen concentrations and/or variations in the T cell, B cell and macrophage subpopulations of mouse spleen cell preparations may influence both the occurrence and the extent of the observed suppression. Such variations may, even more so, account for similar inconsistencies observed in vivo. Studies are at present being carried out to define more exactly the conditions associated with the suppression of antibody formation in vitro. The reasons for the reduced antibody levels associated with the detergent-extracted SV preparations are unknown. Inherent in the findings are two situations that need to be explained mechanistically. First, there is the nature of the interaction between detergent-split influenza virus preparations and the immune system, which results in a reduced response compared to that seen following inoculation of WV vaccine. Secondly, there is the interaction between the SV preparations and WV vaccine which results in a reduced overall response of animals and cultured spleen cells exposed to mixtures of the two. In this latter situation, one can envisage two general mechanisms, either or both of which could influence the outcome: a direct competitive or interfering effect of subunit preparations on complete virions, or an indirect effect(s) operating through the immune system. These latter effects may be identical to those responsible for the relatively poor immune response induced by the subunits alone. The term 'intermolecular competition' has been used to describe the phenomenon whereby one antigen in a mixture of two interferes with antibody formation to the second (for review, see Taussig, 1977) . In most studies, intermolecular competition has been observed using two different antigens (Tai-Kim et al., 1974; Taussig, 1974) . However, there seems to be no a priori reason why such competition should not occur between antigens bearing presumably similar determinants, but presented to the immune system in different forms. Recent studies (Rock & Benaceraf, 1983) have reported competition, between structurally related antigens, for sites of interaction with major histocompatibility complex (MHC) gene products in antigen presentation. Although competition may determine the suppressive effects of SV seen in the present studies, the reasons for the markedly lower antibody responses to the detergent-split preparations described here, and indeed for the poor immune response in animals and unprimed individuals to split or subunit influenza virus vaccines in general (Jennings et al., 1981 a) remain unexplained. However, Schwartz et al. (1976 and Adorini et al. (1979) have proposed the existence of distinct 'helper' and 'suppressor' determinants on single antigen molecules, and peptides that may be capable of exclusively activating suppressor cells have been described (Turkin & Sercarz, 1977) . It is conceivable that detergent disruption of influenza virus may yield subunits with exposed 'suppressor determinants' able to tip the regulatory balance towards suppression of antibody production. In this context, it is also possible that novel or altered antigens arising following detergent treatment may have led to an immune response to such altered antigens; this would not have been observed in the antibody assays used in the present studies.
Alternatively, a number of workers have reported that subunits from several viruses, obtained using Triton X-100 or Nonidet P40, fail to stimulate interferon production from human lymphocytes (Ennis & Meager, 1981 ; Casali et al., 1981) . Lack of y-interferon will, in turn, result in a lack of Ia expression on macrophages (Scher et al., 1980; Steeg et al., 1982) . and under such circumstances there is marked antigen recognition by suppressor T cells (Unanue et al., 1984) leading to suppression of the immune response to the antigen concerned.
In view of the recent increased interest in the development of new viral vaccines using virion surface antigens derived by a variety of means, the possibility that these may have modulatory effects on the immune response is important. An understanding of the immune mechanisms whereby such effects are brought about will be of value in facilitating, in the future, the preparation and use of these viral subunits in the most advantageous way.
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